Taiwo Oladapo

Array ( [id] => 4964842 [patent_doc_number] => 20080107662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis' [patent_app_type] => utility [patent_app_number] => 11/632275 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7563 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107662.pdf [firstpage_image] =>[orig_patent_app_number] => 11632275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162094 [patent_doc_number] => 07670792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Biomarkers for early detection of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 11/571986 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24396 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/670/07670792.pdf [firstpage_image] =>[orig_patent_app_number] => 11571986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995093 [patent_doc_number] => 20070010438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Tumor treatment using beta-sheet peptides and radiotherapy' [patent_app_type] => utility [patent_app_number] => 11/176984 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19376 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010438.pdf [firstpage_image] =>[orig_patent_app_number] => 11176984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634305 [patent_doc_number] => 08012754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Antibody compositions' [patent_app_type] => utility [patent_app_number] => 11/173564 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 12815 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012754.pdf [firstpage_image] =>[orig_patent_app_number] => 11173564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726388 [patent_doc_number] => 20060057148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Compositions and methods for treatment of non-hodgkin\'s lymphoma' [patent_app_type] => utility [patent_app_number] => 11/172193 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 51603 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057148.pdf [firstpage_image] =>[orig_patent_app_number] => 11172193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738078 [patent_doc_number] => 20060008468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Combinations of tumor-associated antigens in diagnostics for various types of cancers' [patent_app_type] => utility [patent_app_number] => 11/155288 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20812 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008468.pdf [firstpage_image] =>[orig_patent_app_number] => 11155288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 499642 [patent_doc_number] => 07205118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Nicotinamide N-methyltransferase as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/152765 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7180 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205118.pdf [firstpage_image] =>[orig_patent_app_number] => 11152765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350024 [patent_doc_number] => 20090005385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Treatment or Prevention of Cancer or Cardiovascular Disease with Methenyltetrahydrofolate Synthetases' [patent_app_type] => utility [patent_app_number] => 11/571213 [patent_app_country] => US [patent_app_date] => 2005-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19723 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005385.pdf [firstpage_image] =>[orig_patent_app_number] => 11571213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931170 [patent_doc_number] => 20050282205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'GLUT5 transporters expressed in cancer cells' [patent_app_type] => utility [patent_app_number] => 11/147108 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10874 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282205.pdf [firstpage_image] =>[orig_patent_app_number] => 11147108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10046009 [patent_doc_number] => 09086403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Methods of screening for cell proliferation or neoplastic disorders' [patent_app_type] => utility [patent_app_number] => 11/145331 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20563 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11145331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5819919 [patent_doc_number] => 20060024232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface' [patent_app_type] => utility [patent_app_number] => 11/143919 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20590 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024232.pdf [firstpage_image] =>[orig_patent_app_number] => 11143919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820002 [patent_doc_number] => 20060024315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Vascular targets for detecting, imaging and treating neoplasia or neovasculature' [patent_app_type] => utility [patent_app_number] => 11/143886 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25051 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024315.pdf [firstpage_image] =>[orig_patent_app_number] => 11143886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698232 [patent_doc_number] => 20080220416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Compositions for Inhibiting Cell Growth and Inducing Apoptosis in Cancer Cells and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/569327 [patent_app_country] => US [patent_app_date] => 2005-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 32258 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220416.pdf [firstpage_image] =>[orig_patent_app_number] => 11569327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625861 [patent_doc_number] => 20060264366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Mule: Mcl-1 ubiquitination ligase E3' [patent_app_type] => utility [patent_app_number] => 11/132977 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8589 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264366.pdf [firstpage_image] =>[orig_patent_app_number] => 11132977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103118 [patent_doc_number] => 07723483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Method for enhancing or inhibiting insulin-like growth factor-I' [patent_app_type] => utility [patent_app_number] => 11/123290 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21534 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723483.pdf [firstpage_image] =>[orig_patent_app_number] => 11123290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876770 [patent_doc_number] => 07358335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'ARF-BP1 as mediator of p53-dependent and independent tumor suppression and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/118524 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 22 [patent_no_of_words] => 20766 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358335.pdf [firstpage_image] =>[orig_patent_app_number] => 11118524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710007 [patent_doc_number] => 20060051352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'CEA binding agents and compositions to reverse CEA-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/097252 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 21355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051352.pdf [firstpage_image] =>[orig_patent_app_number] => 11097252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832948 [patent_doc_number] => 20080131495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Mucinous Glycoprotein (Muc-1) Vaccine' [patent_app_type] => utility [patent_app_number] => 10/594992 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15112 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131495.pdf [firstpage_image] =>[orig_patent_app_number] => 10594992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886409 [patent_doc_number] => 20080260741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Preventive and/or Therapeutic Agent for Cancer' [patent_app_type] => utility [patent_app_number] => 11/547334 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7866 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260741.pdf [firstpage_image] =>[orig_patent_app_number] => 11547334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264423 [patent_doc_number] => 20090117108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody' [patent_app_type] => utility [patent_app_number] => 10/594908 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10675 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117108.pdf [firstpage_image] =>[orig_patent_app_number] => 10594908 [rel_patent_id] =>[rel_patent_doc_number] =>)